Scientists develop drug that slows Alzheimer's in mice
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. The findings, ...
Alzheimer's disease & dementia
May 13, 2013 |
4.2 / 5 (5) |
0
|
Scientists identify early predictors of disease progression which could speed Huntington's disease drug trials
Scientists have identified a set of tests that could help identify whether and how Huntington's disease (HD) is progressing in groups of people who are not yet showing symptoms. The latest findings from the TRACK-HD study, ...
Neuroscience
May 08, 2013 |
not rated yet |
0
Ambrisentan not effective in idiopathic pulmonary fibrosis
(HealthDay)—The endothelin A receptor-selective antagonist ambrisentan is not effective for reducing the rate of idiopathic pulmonary fibrosis (IPF) progression, according to a study published in the May ...
Diseases, Conditions, Syndromes
May 07, 2013 |
not rated yet |
0
Scientists much closer to developing screening test for early detection of Alzheimer's disease
They identified blood-based biological markers that are associated with the build up of a toxic protein in the brain which occurs years before symptoms appear and irreversible brain damage has occurred.
Alzheimer's disease & dementia
May 01, 2013 |
not rated yet |
0
Cell response to new coronavirus unveils possible paths to treatments
NIH-supported scientists used lab-grown human lung cells to study the cells' response to infection by a novel human coronavirus (called nCoV) and compiled information about which genes are significantly disrupted ...
Diseases, Conditions, Syndromes
Apr 30, 2013 |
5 / 5 (1) |
0
Team finds melatonin delays ALS symptom onset and death in mice
Melatonin injections delayed symptom onset and reduced mortality in a mouse model of the neurodegenerative condition amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, according to a new study by researchers at ...
Neuroscience
Apr 25, 2013 |
not rated yet |
0
Ingredient in new MS drug linked to serious brain disease
(HealthDay)—The active ingredient in a drug that's expected to become a popular treatment for multiple sclerosis has been linked to four European cases of a rare but sometimes fatal brain disease called ...
Medications
Apr 24, 2013 |
not rated yet |
0
|
Grape intake may protect against metabolic syndrome-related organ damage
Consuming grapes may help protect against organ damage associated with the progression of metabolic syndrome, according to research presented Monday at the Experimental Biology conference in Boston. Natural components found ...
Health
Apr 22, 2013 |
5 / 5 (1) |
0
A noninvasive avenue for Parkinson's disease gene therapy
Researchers at Northeastern University in Boston have developed a gene therapy approach that may one day stop Parkinson's disease (PD) in it tracks, preventing disease progression and reversing its symptoms. The novelty of ...
Parkinson's & Movement disorders
Apr 21, 2013 |
not rated yet |
0
Large-scale genetic study defines relationship between primary sclerosing cholangitis and other autoimmune diseases
For the first time, scientists show that a leading cause of liver transplant, primary sclerosing cholangitis (PSC), is a distinct disease from inflammatory bowel disease, opening up new avenues for specific PSC treatments.
Genetics
Apr 21, 2013 |
not rated yet |
0
|
Study uncovers key factor in Alzheimer's progression
(Medical Xpress)—A new study from researchers at the University of Florida may have uncovered a critical factor that drives the relentless progression of Alzheimer's disease ― a discovery that could eventually slow its ...
Alzheimer's disease & dementia
Apr 16, 2013 |
5 / 5 (1) |
0
|
In-transit melanoma advance is difficult to predict
(HealthDay)—Progressive disease cannot be reliably predicted by patient, clinical, or procedural factors in patients receiving regional therapy for advanced melanoma of the extremities, according to a study ...
Surgery
Apr 15, 2013 |
not rated yet |
0
Potential therapy for HIV suggested: Blocking key protein boosts body's ability to clear chronic infection
UCLA scientists have shown that temporarily blocking a protein critical to immune response actually helps the body clear itself of chronic infection. Published in the April 12 edition of Science, the findin ...
HIV & AIDS
Apr 11, 2013 |
5 / 5 (1) |
0
|
Unusual suspect: Scientists find 'second fiddle' protein's role in Type 2 diabetes
A team of researchers at the Johns Hopkins Children's Center has found that a protein long believed to have a minor role in type 2 diabetes is, in fact, a central player in the development of the condition that affects nearly ...
Diabetes
Apr 11, 2013 |
4 / 5 (1) |
0
|
New target plus new drug equals death of melanoma cells
Collaborative research presented by the University of Colorado Cancer Center, the University of North Carolina at Chapel Hill, Harvard Medical School and the University of Pittsburgh, at the American Association for Cancer ...
Cancer
Apr 09, 2013 |
5 / 5 (1) |
0
